Celanese Corp CE
We take great care to ensure that the data presented and summarized in this overview for Celanese Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CE
View all-
Dodge & Cox San Francisco, CA15.4MShares$828 Million0.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$646 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.15MShares$384 Million0.02% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.98MShares$268 Million0.06% of portfolio
-
Turtle Creek Asset Management Inc. Toronto, A64.51MShares$242 Million7.65% of portfolio
-
Morgan Stanley New York, NY3.8MShares$204 Million0.02% of portfolio
-
State Street Corp Boston, MA3.71MShares$199 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$192 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA3.32MShares$179 Million0.04% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA3.16MShares$170 Million0.71% of portfolio
Latest Institutional Activity in CE
Top Purchases
Top Sells
About CE
Celanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The company operates through three segments: Engineered Materials, Acetate Tow, and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics. It also offers acesulfame potassium, a sweetener for use in various beverages, confections, and dairy products; and food protection ingredients, such as potassium sorbate and sorbic acid for use in foods, beverages, and personal care products. The Acetate Tow segment provides acetate tows and flakes for use in filter products applications. The Acetyl Chain segment produces and supplies acetyl products, including acetic acid, vinyl acetate monomers, acetic anhydride, and acetate esters that are used as starting materials for colorants, paints, adhesives, coatings, and pharmaceuticals; and organic solvents and intermediates for pharmaceutical, agricultural, and chemical products. It also offers vinyl acetate-based emulsions for use in paints and coatings, adhesives, construction, glass fiber, textiles, and paper applications; and ethylene vinyl acetate resins and compounds, as well as low-density polyethylene for use in flexible packaging films, lamination film products, hot melt adhesives, automotive parts, and carpeting applications. In addition, it manufactures ultra-high molecular weight polyethylene. Celanese Corporation was founded in 1918 and is headquartered in Irving, Texas.
Insider Transactions at CE
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 23
2025
|
Mark Christopher Murray SVP - Acetyls |
BUY
Open market or private purchase
|
Direct |
1,479
+8.73%
|
$76,908
$52.18 P/Share
|
May 15
2025
|
Michael Koenig Director |
SELL
Payment of exercise price or tax liability
|
Direct |
335
-5.01%
|
$17,085
$51.45 P/Share
|
May 15
2025
|
Kim K.W. Rucker Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,114
-24.51%
|
-
|
May 15
2025
|
Timothy Go Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,114
-24.81%
|
-
|
May 15
2025
|
Deborah J. Kissire Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,114
-19.93%
|
-
|
May 09
2025
|
Kim K.W. Rucker Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,376
+42.62%
|
-
|
May 09
2025
|
Scott Mc Dougald Sutton Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,376
+15.52%
|
-
|
May 09
2025
|
Ganesh Moorthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,376
+40.23%
|
-
|
May 09
2025
|
Michael Koenig Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,376
+33.53%
|
-
|
May 09
2025
|
Christopher J Kuehn Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,376
+50.0%
|
-
|
May 09
2025
|
Jay V Ihlenfeld Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,376
+17.56%
|
-
|
May 09
2025
|
Deborah J. Kissire Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,376
+37.65%
|
-
|
May 09
2025
|
Edward G Galante Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,090
+17.73%
|
-
|
May 09
2025
|
David F Hoffmeister Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,376
+42.92%
|
-
|
May 09
2025
|
Bruce E. Chinn Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,376
+44.06%
|
-
|
May 09
2025
|
Timothy Go Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,376
+42.92%
|
-
|
May 09
2025
|
Kathryn Hill Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,376
+18.37%
|
-
|
Mar 12
2025
|
Ganesh Moorthy Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+25.0%
|
$53,000
$53.29 P/Share
|
Mar 07
2025
|
Mark Christopher Murray SVP - Acetyls |
BUY
Open market or private purchase
|
Direct |
2,353
+14.4%
|
$127,062
$54.45 P/Share
|
Mar 07
2025
|
Scott Mc Dougald Sutton Director |
BUY
Open market or private purchase
|
Direct |
7,450
+33.18%
|
$402,300
$54.65 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 46.5K shares |
---|---|
Open market or private purchase | 14.3K shares |
Conversion of derivative security | 1.04K shares |
Sale (or disposition) back to the issuer | 3.34K shares |
---|---|
Payment of exercise price or tax liability | 2.65K shares |
Open market or private sale | 9.35K shares |